Dr. Weerapat Owattanapanich

Associate Professor

19 Years of Experience

Hematologist

MD, Diploma, Fellowship

Vejthani Hospital, Bangkok

English, Thai

Consultation Fee $ 24

Book an Appointment

About Dr. Weerapat Owattanapanich

Dr. Weerapat Owattanapanich is a renowned Hematologist with 16 years of experience.
His substantial areas of expertise include leukemia and plasma cell disorders.
He completed his MD at Thammasat University, Bangkok, Thailand, in 2008 and pursued a Hematology Residency at Mahidol University, Siriraj Hospital, Bangkok, Thailand, in 2013.
He gained a Diploma from The Thai Board of Hematology in 2013.
Dr. Weerapat earned a Diploma from the Thai Board of Clinical Pathology in 2019.
He pursued a research fellowship in acute myeloid leukemia and stem cell transplantation at the Department of Internal Medicine III, Ulm University, Germany, in 2019.
He is a member of the Royal College of Physicians of Thailand, the Thai Society of Hematology, and the Acute Leukemia Society of Thailand.

Education

MD, Thammasat University, Bangkok, Thailand, 2008
Diploma of the Thai Board of Hematology, 2013
Diploma of the Thai Board of Clinical Pathology, 2019
Research Fellowship in Acute Myeloid Leukemia and Stem Cell Transplantation, Department of Internal Medicine III, Ulm University, Germany, 2019

Training & Certificates

Hematology Residency, Mahidol University, Siriraj Hospital, Bangkok, Thailand, 2013

Past Experience

Director, Adult Acute Myeloid/Lymphoblastic Leukemia Excellence Center, 2022
Associate Professor, Division of Hematology, Department of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand, 2020

Awards

Thammasat Award, Academic Excellence in Medicine, Surgery, and Pediatrics, 2006

Associations/Membership

Acute Leukemia Society of Thailand
Thai Society of Hematology
Royal College of Physicians of Thailand

Paper Published

Dr. Weerapat Owattanapanich has numerous publications. Some of his papers published are:

Owattanapanich, W., Rungjirajittranon, T., Jantataeme, A., Kungwankiattichai, S., & Ruchutrakool, T. (2023). Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients. Thrombosis Journal, 21(1). https://doi.org/10.1186/s12959-023-00506-2
Ponvilawan, B., Owattanapanich, W., Charoenngam, N., & Kungwankiattichai, S. (2021). Effects of different types of allogeneic hematopoietic stem cell transplantation donors on Philadelphia chromosome-positive acute lymphoblastic leukemia during the tyrosine kinase inhibitor era: A systematic review and meta-analysis. Hematology/Oncology and Stem Cell Therapy. https://doi.org/10.1016/j.hemonc.2021.09.007
Treewaree S, Kulthamrongsri N, Owattanapanich W, Krittayaphong R. Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An updated systematic review and meta-analysis. Front Cardiovasc Med. 2023 Feb 7;10:1046194. doi: 10.3389/fcvm.2023.1046194. PMID: 36824458; PMCID: PMC9941559.
Anamnart C, Tisavipat N, Owattanapanich W, Apiwattanakul M, Savangned P, Prayoonwiwat N, Siritho S, Rattanathamsakul N, Jitprapaikulsan J. Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review. Mult Scler Relat Disord. 2022 Feb;58:103414. doi: 10.1016/j.msard.2021.103414. Epub 2021 Nov 18. PMID: 35216789.
Apiraksattayakul N, Songwisit S, Owattanapanich W, Tisavipat N, Siritho S, Prayoonwiwat N, Rattanathamsakul N, Jitprapaikulsan J. AQP4-IgG-positive neuromyelitis optica spectrum disorder and temporally detected neoplasms: case report and systematic review. Mult Scler Relat Disord. 2022 Dec;68:104212. doi: 10.1016/j.msard.2022.104212. Epub 2022 Oct 4. PMID: 36242805.
Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Rattarittamrong E, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C. Comparison of Three Doses of Cytarabine Consolidation for Intermediate- and Adverse-risk Acute Myeloid Leukemia: Real World Evidence From Thai Acute Myeloid Leukemia Registry. Clin Lymphoma Myeloma Leuk. 2022 Oct;22(10):e915-e921. doi: 10.1016/j.clml.2022.06.005. Epub 2022 Jun 12. PMID: 35792033.
Chanswangphuwana C, Polprasert C, Owattanapanich W, Kungwankiattichai S, Tantiworawit A, Rattanathammethee T, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Nakhakes C, Prayongratana K, Sriswasdi C. Characteristics and Outcomes of Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes: Multicenter Study From the Thai Acute Leukemia Study Group. Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):e1075-e1083. doi: 10.1016/j.clml.2022.08.010. Epub 2022 Aug 23. PMID: 36117042.
Jirabanditsakul C, Dakeng S, Kunacheewa C, U-Pratya Y, Owattanapanich W. Comparison of Clinical Characteristics and Genetic Aberrations of Plasma Cell Disorders in Thailand Population. Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221111228. doi: 10.1177/15330338221111228. PMID: 35770320; PMCID: PMC9252016.